Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Clinical trial NCT03723681 · COMPLETED
Trial details
- NCT number
- NCT03723681
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-05
- Primary completion
- 2022-03-03
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.